Introduction
Maintaining the integrity of the genome is a key to stable inheritance of genetic information through generations. To achieve this, cells respond to DNA damages by activating a network called checkpoint to delay cell cycle progression and repair lesions. The phosphatidylinositol kinase-related protein kinases, ataxia-telangiectasia-mutated (ATM) and ATM-Rad3-related (ATR), are important regulators for cellular responses to DNA damages (Abraham, 2001) . In response to stalled DNA replication forks, ATR is activated and prevents the onset of mitosis by activating Chk1, an effector kinase for checkpoint responses (Shechter et al., 2004) . Together with Chk2, it regulates various cellular functions such as DNA replication, cell division, chromatin reorganization and apoptosis. Accumulating evidence suggests that ATR-dependent phosphorylation of Chk1 is essential for its activation following DNA damages and replication stresses (Bartek and Lukas, 2003; Chen and Sanchez, 2004) .
The activation of Chk1 also depends on the checkpoint mediator, Claspin (Kumagai and Dunphy, 2000; Chini and Chen, 2003; Lin et al., 2004) . Claspin associates with chromatin in a highly specific manner during the course of DNA replication , suggesting its role in monitoring the integrity of DNA replication complexes. In support of this possibility, Mrc1, the potential functional equivalent of Claspin in yeasts, interacts with replisome machinery and plays essential roles in the activation of Rad53 and Cds1 (the budding and fission yeast orthologs of Chk2) (Alcasabas et al., 2001; Tanaka and Russell, 2001; Osborn and Elledge, 2003; Zhao et al., 2003) . Also, Xenopus Claspin has been shown to interact with replication and checkpoint proteins, including Cdc45, DNA polymerase e, replication protein A (RPA) and RFC complexes (Lee et al., 2005) .
Claspin is hyperphosphorylated in response to replication fork stalling, and this phosphorylation is essential for association with and activation of Chk1 Dunphy, 2000, 2003; Chini and Chen, 2003; Jeong et al., 2003; Lin et al., 2004) . ATM and/or ATR have been implicated in Claspin phosphorylation during replication checkpoint (Chini and Chen, 2003; Kumagai and Dunphy, 2003; Lee et al., 2003) . Recently, it was reported that Claspin abundance is controlled through the ubiquitin-proteasome pathway and that the degradation of Claspin is a mechanism that turns off checkpoint upon completion of DNA repair (Mailand et al., 2006; Mamely et al., 2006; Peschiaroli et al., 2006; Zhang et al., 2006) . It was also reported that Claspin is cleaved by caspase-7 which inactivates the Chk1 signaling pathway (Clarke et al., 2005) .
A serine/threonine kinase Cdc7 and its associating regulatory subunit Dbf4 are evolutionarily conserved and regulate the initiation and progression of DNA replication at least partly through phosphorylation of minichromosomal maintenance (MCM) proteins (Sclafani, 2000; Masai and Arai, 2002; Montagnoli et al., 2006) . Genetic analyses in yeasts also pointed to Cdc7 and Dbf4 as potential targets of the hydroxyurea (HU)-induced intra-S-phase checkpoint. Budding yeast Dbf4 and its fission yeast ortholog Dfp1/Him1 are phosphorylated following HU treatment in a manner dependent on Rad53 and Cds1, respectively (Brown and Kelly, 1999; Takeda et al., 1999 Takeda et al., , 2001 Weinreich and Stillman, 1999; Kihara et al., 2000) . In Xenopus egg extracts, it has been reported that Cdc7 kinase activity is downregulated after DNA damages, inhibiting chromatin loading of Cdc45 and further origin firing (Costanzo et al., 2003) . These observations suggest that the inhibition of Cdc7 activity might be one of the effector mechanisms targeted by replication checkpoint responses. On the other hand, it has also been demonstrated that Cdc7 kinase complex remains active after DNA damages in both Xenopus (Yanow et al., 2003) and humans (Tenca et al., 2007) , suggesting its positive role in checkpoint responses. The role for Cdc7 as a mediator of replication checkpoint signaling has also been suggested by the finding that HU-induced activation of Cds1 was significantly impaired in a temperature-sensitive (ts) strain of hsk1 (Takeda et al., 2001) . However, the mechanism by which Cdc7 mediates DNA replication checkpoint responses remains elusive.
In this study, we demonstrate that Cdc7 depletion leads to defects in HU-induced activation of Chk1 and to enhanced sensitivity against HU. HU-induced chromosome recruitment of ATR and Rad17 occurred normally in the absence of Cdc7, indicating that sensory machinery for replication arrest operates properly in the absence of Cdc7. We provide evidence for the direct role of Cdc7 in phosphorylation and chromatin association of Claspin, and propose that Cdc7 plays an essential role in mediating the ATR-Chk1 pathway through regulation of Claspin.
Results
Cdc7 is required for the activation of DNA replication checkpoint in embryonic stem cells To determine whether Cdc7 plays a role in DNA damage and replication checkpoints, we utilized Cdc7 À/À tg embryonic stem (ES) cells, which we previously generated (Kim et al., 2002) . This cell line lacks both alleles of the endogenous Cdc7, but its viability is maintained by a flox transgene encoding the Cdc7. Murine Cdc7 protein is expressed in two different isoforms (muCdc7-L and -S) and muCdc7-S, encoding the shorter form, can perfectly complement Cdc7 deficiency in ES cells (Kim et al., 2002) . Within 2 days after infection with Creexpressing adenovirus (Ad-Cre), the level of Cdc7 in Cdc7 À/À tg ES cells became nearly undetectable (Figure 1a) . At 2.5 days after Ad-Cre infection, the cells were exposed to ionizing or ultraviolet radiation (IR or UV, respectively) or HU. In wild-type ES cells, UV and HU treatments induced phosphorylation of Chk1 on Ser317 (Figure 1b) , whereas IR treatment induced phosphorylation of Chk2 on Thr387 (Figure 1c ). In contrast, Cdc7-deficient ES cells showed barely detectable phospho-Ser317 on Chk1 following UV and HU treatments. IR-induced phosphorylation of Chk2 on Thr387 was not affected by the loss of Cdc7. Thus, HU-and UVinduced Chk1 activations are selectively impaired in Cdc7-deficient ES cells.
Cdc7-depletion leads to impaired HU-induced checkpoint in human cancer cell lines To further examine the role of Cdc7 in replication checkpoint, we used a small interfering RNA (siRNA) to suppress Cdc7 expression in human cancer cell lines. Immunoblotting revealed that the Cdc7 siRNA abolished the Cdc7 expression almost completely (Figure 2a) . Following HU treatment, cells transfected with Cdc7 siRNA showed markedly decreased phosphorylation of Chk1 (Figure 2a) . Importantly, the defect in HU-induced Chk1 activation was observed acutely in Cdc7 siRNA-treated cells, in which DNA replication did occur, although at a moderately reduced rate, as determined by bromodeoxyuridine staining and thymidine incorporation (Figure 2a and Supplementary  Figure 1 ). This defect was Chk1-specific, since HU-induced Chk2 activation (pThr68-Chk2) was not impaired by Cdc7 siRNA (Supplementary Figure 2) . Chk1 activation by aphydicolin, an inhibitor of DNA polymerase-a, was also impaired in Cdc7-depleted cells (data not shown). Taken together, these results indicate that the activation of Chk1 by replication block is specifically impaired in Cdc7-depleted cells, as was observed in Cdc7-deficient ES cells (Figure 1 ). Terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) analysis revealed that an increased proportion of Cdc7 siRNA-treated cells underwent cell death upon HU treatment (Figure 2b ). Hypersensitivity to HU has also been reported for budding yeast cdc7 ts and fission yeast hsk1 ts strains (Takeda et al., 1999; Weinreich and Stillman, 1999; Matsumoto et al., 2005) , and recently for Cdc7-depleted human cancer cell lines (Tenca et al., 2007) . Thus, Cdc7-depleted cells have defect in the checkpoint responses to replication fork arrest, which leads to elevated sensitivity to HU treatment.
Interestingly, we have detected enhanced Chk2 activation (pThr68-Chk2) and g-H2AX in Cdc7 siR-NA-treated cells ( Figure 2c and Supplementary Figure  2) . We quantified the percentage of g-H2AX-positive cells by fluorescence activated cell sorter analysis after siRNA transfection in HeLa and U2OS cells. At 48 and 72 h after Cdc7 siRNA transfection, enhanced phosphorylation of H2AX was observed (Figure 2d ), although not as extensive as after treatment with DNAdamaging agents such as camptothecin, etoposide and methylmethane sulfate (MMS) (data not shown). These results suggest that Cdc7 depletion may cause spontaneous DNA damage, which might resemble doublestranded DNA break (DSB)-like structures.
HU-induced relocalization of ATR is unperturbed by Cdc7 depletion
Recruitment of ATR to the sites of stalled DNA replication forks is a critical early event during replication checkpoint responses. As shown in Figure 3a , ATR was mostly present in the Triton-soluble (cytosolic and nucleoplasmic; S) fractions in normal cells. Upon treatment with HU, approximately half of the ATR relocated to the Triton-insoluble (chromatin-enriched; P) fractions in both control and Cdc7 siRNAtransfected cells (Figure 3a ). In addition, HU treatment induced formation of ATR-containing nuclear foci (Tibbetts et al., 2000) in both control and Cdc7 siRNA-transfected cells at a similar level (Figure 3b ).
Rad17 is another key protein in the ATR-dependent checkpoint signaling (Bao et al., 2001; Zou et al., 2002; Wang et al., 2003) . A portion of Rad17 relocated to chromatin-enriched fractions following HU treatment, and this relocation was not affected by Cdc7 siRNA (Figure 3a) . Nbs1 is required for the recruitment or retention of ATR at sites of stalled replication forks, and this colocalization is required for ATR-dependent phosphorylation of Chk1 after replication fork stalling (Robison et al., 2004; Stiff et al., 2005) . No appreciable decrease of Nbs1 was observed in chromatin-enriched fractions of Cdc7 siRNA-transfected cells, with or without HU treatment (Figure 3a) . Together, these results indicate that Cdc7 depletion does not affect damage-induced relocalization of checkpoint sensor proteins.
As ATR is also activated by DSBs, it remains possible that DSBs potentially generated by HU in Cdc7 siRNAtreated cells cause Rad17/ATR activation. However, Chk1 activation was detected as early as 15 min after HU addition, when H2AX was still not phosphorylated, and this Chk1 activation was suppressed by Cdc7 depletion (Supplementary Figure 3a) . In control, treatment with MMS for 6.5 h induced strong Chk1 phosphorylation as well as g-H2AX signal. Interestingly, Chk1 phosphorylation under this condition was not affected by Cdc7 depletion (Supplementary  Figure 3b) . This strongly suggests that fork perturbation itself is likely to be responsible for activation of these sensor proteins, leading us to conclude that Cdc7 depletion does not affect the steps at which stalled replication forks are detected by checkpoint sensors.
Cdc7 depletion causes failure in phosphorylation and chromatin association of Claspin Claspin has been suggested to be associated with DNA replication machinery Lee et al., 2005) and plays essential roles in the regulation of Chk1 (Kumagai and Dunphy, 2000; Chini and Chen, 2003; Lin et al., 2004) . We found that the amount of Claspin was considerably reduced by the depletion of Cdc7 (Figure 4a ). The decrease was partially rescued by treatment with the proteasome inhibitor MG132, suggesting that protein degradation at least partially accounts for the decrease (Figure 4b ). To examine whether the diminished expression of Claspin underlies impaired Chk1 activation in Cdc7-depleted cells, we compared the effect of Cdc7 and Claspin downregulation on Chk1 activation. Transfection of Claspin siRNA downregulated Claspin expression to an almost undetectable level, and this led to the reduction of Chk1 phosphorylation on Ser317 (Figure 4a ) and Ser345 (Figure 4c ), as previously demonstrated (Chini and Chen, 2003; Lin et al., 2004) . However, Chk1 phosphorylation on these residues was much more severely reduced in Cdc7 siRNA-treated cells, despite the fact that Claspin was clearly detectable (Figures 4a and c) . Therefore, the reduced level of Claspin per se does not fully explain the loss of Chk1 activation in Cdc7-depleted cells, and some qualitative alteration of Claspin may be responsible for it. Following HU treatment, mobility-shifted forms of Claspin accumulated in the chromatin-enriched fractions (Figure 4c ). The observed mobility shift of Claspin disappeared following the phosphatase treatment, confirming that it is caused by phosphorylation (Supplementary Figure 4) . In Claspin siRNA-transfected cells, hyperphosphorylated forms of Claspin were clearly detected in the chromatin fraction, albeit at a reduced level, after long exposure. In contrast, phosphorylated forms of Claspin were undetectable in Cdc7 siRNA-treated cells even after long exposure, although a non-phosphorylated form was detected in Triton-soluble fractions (Figure 4c) . Moreover, in Cdc7 À/À tg ES cells, Claspin protein level was not altered whereas Chk1 activation was substantially reduced (Figure 4d) . Furthermore, when we ectopically expressed Flag-tagged Claspin, Chk1 phosphorylation was nonetheless inactivated in Cdc7 siRNA-treated cells, although the Claspin protein level was equally maintained in control and Cdc7 siRNA-treated cells (Supplementary Figure 5) . Taken together, these results strongly favor the idea that the loss of phosphorylation and chromatin accumulation of Claspin after Cdc7 downregulation causes impaired checkpoint kinase activation.
Cdc7 interacts with and phosphorylates Claspin
The results described so far strongly suggest functional interaction between Cdc7 and Claspin. We found that Cdc7 physically interacts with Claspin. As shown in Figure 5a , approximately 1/20 of input was immunoprecipitated with anti-Claspin antibody in asynchronously growing as well as in HU-treated HeLa cells. The interaction of Cdc7 with Claspin was also confirmed in cell cycle-synchronized extracts (Supplementary Figure 6) .
We also found that Claspin is an efficient substrate of Cdc7 kinase in vitro. When incubated with purified Cdc7-ASK (an associating regulatory subunit of Cdc7; Kumagai et al., 1999) complex, specific phosphorylation of purified glutathione S-transferase (GST)-Claspin was observed (Figure 5b) . Quantification of the g-32 P incorporation revealed that approximately two molecules of phosphates were incorporated per molecule of Claspin. This is almost equivalent to what had been observed with Cdc7-mediated phosphorylation of MCM2 in the MCM2-4-6-7 complex (Masai et al., 2000) . Moreover, mobility-shift of ectopically expressed Claspin was observed when coexpressed with Cdc7-ASK complex (Figure 5c ). This mobility shift is due to phosphorylation, as it was eliminated by phosphatase treatment. Endogenous Claspin was also hyperphosphorylated upon overexpression of Cdc7-ASK complex (data not shown). Together, these results indicate that Cdc7 can phosphorylate Claspin both in vivo and in vitro.
Discussion
Cdc7 plays an essential role in replication checkpoint through regulating Claspin In this report, we have explored a novel function of Cdc7, a kinase essential for initiation of DNA replication, in replication checkpoint signaling. In the absence Figure 5 Cdc7 interacts with and phosphorylates Claspin. (a) Asynchronously growing HeLa cells were either untreated or treated with 10 mM HU for 2 h. The cell extracts were immunoprecipitated with anti-Claspin antibody or control IgG. The input extracts (2.5%) and immunoprecipitates were immunoblotted with antibody against Claspin or Cdc7. (b) Purified GST or GSTClaspin was incubated with graded amounts of purified Cdc7-ASK complex in vitro in the presence of [g-32 P]ATP. SDS-PAGE gel was stained with silver (lower panel) and was dried for autoradiogram (upper panel) . The amounts of Cdc7-ASK added were as follows: À, none; þ , 50 ng; þ þ , 100 ng. The incorporated phosphates per mole substrate protein were determined by measuring the radioactivity of the bands with a scintillation counter. (c) 293T cells were transfected with combinations of the plasmids encoding HA-Cdc7, Myc-ASK and Flag-Claspin. The cell lysates were immunoblotted with anti-Flag or anti-a-tubulin antibodies. PPase: the cell lysates were treated with l phosphatase. The arrowhead indicates the phosphorylated bands. GST, glutathione S-transferase; HU, hydroxyurea; IgG, immunoglobulin G; IP, immunoprecipitates SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Role of Cdc7 in replication checkpoint JM Kim et al of Cdc7, HU-induced Chk1 phosphorylation was impaired both in mouse ES cells (Figure 1 ) and human cancer cell lines, including HeLa and U2OS cells (Figures 2-4) . Depletion of Cdc7 considerably reduced Chk1 activation, even at an early time point when the level of DNA synthesis was only modestly reduced ( Figure 2a and Supplementary Figure 1) . Also, the loading of RPA onto chromatin was not affected by Cdc7 depletion (Supplementary Figure 7) . These observations argue against the possibility that the loss of HU-induced Chk1 activation in Cdc7-depleted cells is solely ascribed to the lack of ongoing DNA replication, which would result in the failure in the generation of checkpoint signal. Rather, we presume that Cdc7 mediates Chk1 activation independently of its role in the initiation of DNA replication. Such bifurcated functions have been proposed previously for MCM7 (Cortez et al., 2004) . It should be noted that Cdc7 is required specifically for acute cellular responses to replication block where significant DSB is not generated (Supplementary Figure 3a) . After extensive DNA damage, Chk1 is activated in the absence of Cdc7 (Supplementary Figure 3b) , presumably through the ATM pathway, indicating that Cdc7 is required specifically for the ATR pathway.
Proficient chromosome recruitment of ATR was observed in Cdc7-depleted cells upon HU treatment (Figure 3 ). This strongly suggests that the target(s) of Cdc7 be positioned downstream of ATR, although we cannot completely exclude the possibility that Cdc7 depletion affects the optimal activation of ATR. We have identified Claspin, a key regulator for Chk1, as a potential target of Cdc7 kinase in checkpoint activation. Cdc7 siRNA-treated cells failed to show HU-induced phosphorylation and chromatin association of Claspin (Figures 4a and c) . Moreover, Cdc7 physically interacted with (Figure 5a and Supplementary Figure 6 ) and directly phosphorylated Claspin (Figures 5b and c) . Considering an essential role for Claspin in Chk1 activation, it is likely that the defect in Claspin activation is primarily responsible for the impaired activation of Chk1 in Cdc7-depleted cells.
At present, the mechanism underlying Cdc7-mediated regulation of Claspin is not known. Cdc7-mediated phosphorylation of Claspin may be necessary for its chromatin association, which may be a prerequisite step for ATR-mediated phosphorylation and activation of Claspin at stalled replication forks. Alternatively, Cdc7 may be required for the assembly of functional replication forks that can respond to various replication stresses. Loss of Cdc7 may result in defective replication forks in which Claspin cannot be properly phosphorylated by ATR. Identification and characterization of Cdc7-mediated phosphorylation sites of Claspin would provide further insights into the mechanism by which Claspin is regulated under normal and DNA replication-perturbed conditions.
The association of Cdc7 with Claspin was detected during an unperturbed cell cycle (Figure 5a and Supplementary Figure 6 ). We are uncertain whether the interaction between Cdc7 and Claspin is a direct one or not at this moment, although the interaction does not involve DNA as they interact in the absence of any detectable DNA after extensive DNase I treatment (Supplementary Figure 6) . It is conceivable that Cdc7-mediated phosphorylation of Claspin plays an essential role in its chromatin association and monitoring of genome integrity during the unperturbed cell cycle. In line with that idea, Claspin phosphorylation increased during the unperturbed S phase when the Cdc7-ASK complex is associated with chromatin and its kinase activity reaches a maximum (Supplementary Figure 8) .
Cdc7 may be required for stabilization of arrested replication In yeasts, in addition to Mrc1, Tof/Swi1-Csm3/Swi3, designated the 'fork protection complex', was proposed to play a role in the stabilization of arrested replication forks (Katou et al., 2003; Noguchi et al., 2004; Nedelcheva et al., 2005) . Genetic and physical interactions of Hsk1 with Swi1 have been reported (Matsumoto et al., 2005; Sommariva et al., 2005) . DNA damages accumulate not only after replication fork block but also during the normal course of S phase in hsk1 ts cells, as is observed in mutants of the component of fork protection complex (Matsumoto et al., 2005) . Cdc7 depletion in human cells led to the accumulation of DNA damage, as indicated by the increased g-H2AX signal (Figure 2d ). Thus, it seems likely that Cdc7 plays a role in maintaining the integrity of the replication forks, presumably by facilitating the stabilization of stalled forks in cooperation with Claspin and other forkstabilizing factors.
Roles of Cdc7 as both checkpoint mediator and effector It has been proposed that the disruption of Cdc7-Dbf4 interaction and subsequent downregulation of Cdc7 kinase activity is an effector mechanism targeted by the etoposide-induced checkpoint signaling mediated by ATR in Xenopus egg extracts (Costanzo et al., 2003) . The study showed that the inhibition of Cdc7 kinase activity led to the failure of Cdc45 loading to chromatin, thus preventing the initiation of DNA replication at late origins. In contrast, it has also been demonstrated that the kinase activity of Cdc7 is not affected by a replication block induced by aphidicolin treatment in Xenopus system (Yanow et al., 2003) . Moreover, it was recently reported that Cdc7 retains its kinase activity after replication stress in human cells (Tenca et al., 2007) . In yeast, in vitro kinase activity of Cdc7 is inhibited by prior phosphorylation by Rad53 (Kihara et al., 2000) . Rad53 also binds to Dbf4, mediating the suppression of late origin firings (Duncker et al., 2002) . Thus, the roles of Cdc7 in the effector phase of intra-Sphase checkpoint may vary from one species to another. On the other hand, our results reported here and previously (Takeda et al., 2001) show the critical requirement of Cdc7 in replication stress-induced activation of checkpoint kinases in yeasts and mammals, suggesting more conserved roles of Cdc7 in the mediator phase of checkpoint.
Materials and methods
Cells ES, HeLa and U2OS cells were maintained as described previously (Kim et al., 2002; Masai et al., 2006) . siRNA Cells were transfected twice (24 h interval) with siRNA duplexes by using the Oligofectamine (Invitrogen, Carlsbad, CA, USA), unless stated otherwise. Cdc7 (Cdc7-1, Cdc7-D and Cdc7-nc) and Luciferase siRNAs have been described previously (Montagnoli et al., 2004; Yoshizawa-Sugata et al., 2005; Masai et al., 2006) . Claspin siRNA has been described (Yoshizawa-Sugata and Masai, 2007) .
Adenoviral infection and TUNEL analysis
Adenoviral infection and TUNEL analysis were performed as described previously (Kim et al., 2002) .
In vitro kinase assay
The entire coding sequence of human Claspin cDNA was isolated from HeLa cells by reverse transcriptase PCR. In vitro kinase assay was performed as described previously (Masai et al., 2000) , using GST or GST-Claspin with purified GST-Cdc7-ASK complex. In phosphatase treatment experiments, cell lysates were incubated with l phosphatase for 30 min at 30 1C.
Methodology for measurement of [
3 H]-thymidine incorporation, cell fractionation, cell-cycle analysis, immunofluorescent staining, immunoblotting, immunoprecipitation and antibodies used in this study are described in Supplementary Information.
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